Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
U.S. healthcare regulators put their highest-risk Class I label on Medtronic’s Paradigm insulin infusion pump recall.
Thirty of Intuitive Surgical’s da Vinci surgical robots might not have been properly tested, according to the FDA, which issues a Class II recall on some models and components of the device.
Abbott agrees to pay $310 million for peripheral stent maker IDEV Technologies and up to $400 million for OptiMedica, which makes laser cataract surgery devices.